Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary
Background: Psychotropic concomitant medication use for the treatment of youth with emotional and behavioral disorders has grown significantly in the U.S. over the past 25 years. The use of pharmacy claims to analyze these trends requires the following: age of the selected population, overlapping da...
Main Authors: | Julie M. Zito, Yue Zhu, Daniel J. Safer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2021.644741/full |
Similar Items
-
Psychotropic Polypharmacy in Outpatients with Schizophrenia: Comparison of Oral Psychotropic Adherence Rates, Duplication of Therapy, Psychiatric Hospitalizations, Cost of Services, and Concomitant Medications
by: Confer, Jennifer, et al.
Published: (2007) -
High-level psychotropic polypharmacy: a retrospective comparison of children in foster care to their peers on Medicaid
by: Deborah Winders Davis, et al.
Published: (2021-06-01) -
Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility
by: Gilles Loggia, et al.
Published: (2020-01-01) -
Polypharmacy in psychiatric practice in the Canary Islands
by: Sanz Emilio J, et al.
Published: (2004-07-01) -
Pattern of Psychotropic Drug Prescription in the Elderly with Chronic Schizophrenia
by: Mohamad Reza Khodaei Ardakani, et al.
Published: (2013-04-01)